This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Lian, T-Y Articles by Chng, H-H Search for Related Content PubMed PubMed Citation Articles by Lian, T-Y Articles by Chng, H-H Social Bookmarking                         What's this?

Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital

Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, tsui_yee_lian{at}ttsh.com.sg

C J Edwards

Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore, Department of Rheumatology, Southampton General Hospital, UK

S-P Chan

Clinical Research Unit, Tan Tock Seng Hospital, Singapore

H-H Chng

Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, Singapore

Patients with systemic lupus erythematosus (SLE) frequently have gastrointestinal (GI) symptoms. These are usually self-limiting and related to treatment side-effects or concurrent illness. However, abdominal pain may be due to bowel ischaemia which can lead to infarction and perforation. The likelihood of these serious events is increased in individuals with pain severe enough to require assessment in hospital or a SLEDAI score > 5. This paper describes a group of patients with active SLE and GI symptoms severe enough to require admission to hospital using a retrospectivereview of 52 SLE patients admitted to hospital with acute abdominal symptoms. The results showed that abdominal pain (87%), vomiting (82%) and diarrhoea (67%) had been present for a mean of 4.4 + 6.5 days and SLEDAI score was 4 in 83% of patients. CT scanning showed evidence of serositis and bowel involvementin 63% of patients who underwent this investigation.Intravenous(iv) fluids were used in 87%, parenteral steroids in 90% and iv cyclophosphamidein 31%. Most (n 51) were discharged well. Recurrence of GI symptoms occurred in 12 patients. The conclusions are that active SLE may manifest as an acute gastrointestinal syndrome. Early diagnosis, bowel rest, supportive medical therapy and treatment with corticosteroids and/or immunosupressives can result in a good outcome.

Key Words: abdominal pain • serositis • SLE • vasculitis

Lupus, Vol. 12, No. 8, 612-616 (2003)
DOI: 10.1191/0961203303lu433oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S.-K. Kwok, S.-H. Seo, J.H. Ju, K.-S. Park, C.-H. Yoon, W.-U. Kim, J.-K. Min, S.-H. Park, C.-S. Cho, and H.-Y. Kim Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody Lupus, October 1, 2007; 16(10): 803 - 809. [Abstract] [PDF]

				L. Waite and E. Morrison Letter To the Editor: Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy) Lupus, October 1, 2007; 16(10): 841 - 842. [PDF]

				M Kishimoto, A Nasir, A Mor, and H. Belmont Acute gastrointestinal distress syndrome in patients with systemic lupus erythematosus Lupus, February 1, 2007; 16(2): 137 - 141. [Abstract] [PDF]

				W G Law, B Y. Thong, T Umapathi, and H H Chng Letter to the Editor Lupus, December 1, 2006; 15(12): 899 - 900. [PDF]